163 related articles for article (PubMed ID: 19786468)
1. Incidence and causes of heparin-induced skin lesions.
Schindewolf M; Schwaner S; Wolter M; Kroll H; Recke A; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
CMAJ; 2009 Oct; 181(8):477-81. PubMed ID: 19786468
[TBL] [Abstract][Full Text] [Related]
2. Low allergenic potential with fondaparinux: results of a prospective investigation.
Schindewolf M; Scheuermann J; Kroll H; Garbaraviciene J; Hecking C; Marzi I; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
Mayo Clin Proc; 2010 Oct; 85(10):913-9. PubMed ID: 20843983
[TBL] [Abstract][Full Text] [Related]
3. High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy.
Schindewolf M; Gobst C; Kroll H; Recke A; Louwen F; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
J Allergy Clin Immunol; 2013 Jul; 132(1):131-9. PubMed ID: 23726261
[TBL] [Abstract][Full Text] [Related]
4. Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin.
Koch P; Hindi S; Landwehr D
Contact Dermatitis; 1996 Feb; 34(2):156-8. PubMed ID: 8681559
[No Abstract] [Full Text] [Related]
5. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.
Girolami B; Prandoni P; Stefani PM; Tanduo C; Sabbion P; Eichler P; Ramon R; Baggio G; Fabris F; Girolami A
Blood; 2003 Apr; 101(8):2955-9. PubMed ID: 12480713
[TBL] [Abstract][Full Text] [Related]
6. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced skin lesions.
Schindewolf M; Lindhoff-Last E; Ludwig RJ; Boehncke WH
Lancet; 2012 Nov; 380(9856):1867-79. PubMed ID: 22642893
[TBL] [Abstract][Full Text] [Related]
9. Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses.
Schindewolf M; Recke A; Zillikens D; Lindhoff-Last E; Ludwig RJ
Contact Dermatitis; 2017 Jul; 77(1):35-41. PubMed ID: 28294347
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to heparin: delayed onset thrombocytopenia and necrotizing skin lesions.
Platell CF; Tan EG
Aust N Z J Surg; 1986 Aug; 56(8):621-3. PubMed ID: 2944502
[TBL] [Abstract][Full Text] [Related]
11. [Heparins and skin reactions: from diagnostic to management].
Barouti N; Masouyé I; Boehncke WH; Prins C
Rev Med Suisse; 2013 Apr; 9(380):705-6, 708-11. PubMed ID: 23621039
[TBL] [Abstract][Full Text] [Related]
12. Delayed hypersensitivity to enoxaparin.
Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
[TBL] [Abstract][Full Text] [Related]
13. [A study of 19 cases of allergy to heparins with positive skin testing].
Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
[TBL] [Abstract][Full Text] [Related]
14. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery.
Lindhoff-Last E; Eichler P; Stein M; Plagemann J; Gerdsen F; Wagner R; Ehrly AM; Bauersachs R
Thromb Res; 2000 Mar; 97(6):387-93. PubMed ID: 10704647
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia.
Schindewolf M; Kroll H; Ackermann H; Garbaraviciene J; Kaufmann R; Boehncke WH; Ludwig RJ; Lindhoff-Last E
J Thromb Haemost; 2010 Jul; 8(7):1486-91. PubMed ID: 20128858
[TBL] [Abstract][Full Text] [Related]
16. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
Bircher AJ; Flückiger R; Buchner SA
Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
[TBL] [Abstract][Full Text] [Related]
17. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
Höhnke C; Haas S
Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.
Schindewolf M; Paulik M; Kroll H; Kaufmann R; Wolter M; Boehncke WH; Lindhoff-Last E; Recke A; Ludwig RJ
Clin Exp Allergy; 2018 Aug; 48(8):1016-1024. PubMed ID: 29683226
[TBL] [Abstract][Full Text] [Related]
19. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
Wütschert R; Piletta P; Bounameaux H
Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study.
Warkentin TE; Roberts RS; Hirsh J; Kelton JG
Chest; 2005 May; 127(5):1857-61. PubMed ID: 15888871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
